The AI revolution is a double-edged sword for software. While some firms will boost margins using AI for development, many others, particularly smaller, leveraged companies, face existential disruption. This creates significant shorting opportunities for investors who look beyond current earnings to future terminal value.

Despite its theoretical role as a market check, short selling is often a tool to create chaos and innuendo for profit. Activist short-sellers release reports to move markets for their own gain, which rarely uncovers true malfeasance and is an extremely difficult way to consistently make money. It's more about creating narratives than finding fraud.

Despite stepping down as CEO, founder Jared Isaacman retains a massive stake and has explicitly stated his successor is "losing a boss and getting a very activist shareholder." This provides comfort that the company's vision and capital allocation discipline will remain intact.

A specific arbitrage opportunity exists with serial acquirers. When they announce a deal that will significantly increase future earnings per share, the market often under-reacts. An investor can buy shares at a compressed forward multiple before the full impact of the acquisition is priced in.

Early-stage biotech companies are vulnerable to short selling in public markets because their experiments run for 12-24 months, creating long periods without news flow. With no catalysts to drive buying ("no bid"), hedge funds can short the stocks until data is released, highlighting a structural disadvantage of being public too early.

Block cautions against shorting mega-caps like NVIDIA based solely on fundamental valuation. He argues that massive passive fund inflows create a powerful "technical value" by squeezing the available float, leading to parabolic price increases that fundamentals alone cannot explain.

The bear case that Shift4's growth will stall as it runs out of legacy POS systems to convert is flawed. In reality, over 80% of new Shift4Dime POS installs are entirely new merchants to the ecosystem, not migrations from older, acquired software platforms.

For many large portfolio managers, an IPO trading below its deal price is a "broken promise." This triggers automatic, price-insensitive selling, regardless of the company's fundamentals. This behavior creates a target for short sellers, who can profit by pushing a stock below its issue price and creating a selling cascade.

When crowded trades in different sectors unwind simultaneously (e.g., a software rally amid a consumer staples sell-off), it's often not a fundamental shift. It can be a market structure sign that large, multi-strategy funds are de-grossing their books.